What is he best known for?
The fields of study he is best known for:
- Immune system
- Cancer
- Antibody
Alan J. Korman spends much of his time researching Immunology, Immunotherapy, Antigen, Immune system and Blockade.
His work deals with themes such as Cytotoxic T cell and Cancer research, which intersect with Immunology.
His Immunotherapy study integrates concerns from other disciplines, such as Monoclonal antibody and Oncology.
Alan J. Korman combines subjects such as Cancer and Primary and secondary antibodies with his study of Monoclonal antibody.
His Oncology study deals with Avelumab intersecting with Breast cancer, Ovarian cancer, Pancreatic cancer and Atezolizumab.
His Ipilimumab research is multidisciplinary, incorporating perspectives in Nivolumab and Clinical trial.
His most cited work include:
- Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. (8133 citations)
- Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer (5176 citations)
- Nivolumab plus Ipilimumab in Advanced Melanoma (3094 citations)
What are the main themes of his work throughout his whole career to date?
His main research concerns Antibody, Immunology, Cancer research, Monoclonal antibody and Cancer.
Alan J. Korman usually deals with Antibody and limits it to topics linked to Molecular biology and Ligand and Cell.
His work focuses on many connections between Immunology and other disciplines, such as Cytotoxic T cell, that overlap with his field of interest in CD8.
His research integrates issues of Immune checkpoint, Receptor, Blockade and Immunotherapy in his study of Cancer research.
His Monoclonal antibody research integrates issues from Programmed death, Programmed death 1, Virology, PD-L1 and Primary and secondary antibodies.
His work investigates the relationship between Ipilimumab and topics such as Nivolumab that intersect with problems in Lung cancer.
He most often published in these fields:
- Antibody (43.98%)
- Immunology (33.33%)
- Cancer research (32.87%)
What were the highlights of his more recent work (between 2018-2021)?
- Antibody (43.98%)
- Cancer research (32.87%)
- Cancer (24.54%)
In recent papers he was focusing on the following fields of study:
Alan J. Korman mainly focuses on Antibody, Cancer research, Cancer, Immune system and Immunotherapy.
His work carried out in the field of Antibody brings together such families of science as Molecular biology, Anti pd 1 and Biochemistry, Nucleic acid.
He interconnects Immune checkpoint and Cytotoxic T cell, CD8, TIGIT in the investigation of issues within Cancer research.
His studies in Cancer integrate themes in fields like Combination therapy and Sarcoma.
His biological study spans a wide range of topics, including Glioma, Receptor and Antigen.
His biological study deals with issues like T cell, which deal with fields such as Radiation therapy, Galectin-1, Downregulation and upregulation and Histidine.
Between 2018 and 2021, his most popular works were:
- Blood-brain barrier permeable nano immunoconjugates induce local immune responses for glioma therapy. (48 citations)
- VISTA is an acidic pH-selective ligand for PSGL-1. (47 citations)
- Targeting DDR2 enhances tumor response to anti–PD-1 immunotherapy (31 citations)
In his most recent research, the most cited papers focused on:
- Immune system
- Cancer
- Antibody
His scientific interests lie mostly in Cancer research, CD8, Cytotoxic T cell, Immune system and Immunotherapy.
His work in Cancer research addresses issues such as Immune checkpoint, which are connected to fields such as Prostate cancer, Myeloid, Cancer cell, Castration Resistance and Tumor progression.
His CD8 research incorporates elements of Blockade and Melanoma.
His research in Cytotoxic T cell tackles topics such as Antibody which are related to areas like Histidine, Cell biology, Glycoprotein and Brain tumor.
Immunotherapy is a primary field of his research addressed under Cancer.
The concepts of his Cancer study are interwoven with issues in Regulatory T cell and Sarcoma.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
